Mazor Robotics Ads (MZOR) 15.78 $MZOR Mazor Robotics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mazor Robotics Ads (MZOR) 15.78 $MZOR

Mazor Robotics Receives Purchase Order from Aventura Hospital and Medical Center in Miami-Dade County
BusinessWire - Thu May 26, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today another Renaissance Guidance System purchase from an HCA Healthcare affiliate hospital, Aventura Hospital and Medical Center. Aventura Hospital is the seventh HCA facility to purchase a Renaissance system and the third hospital in Miami-Dade County to receive a system in the past six months.
MZOR: 15.78 (-0.18)

Mazor Robotics Signs Strategic Commercial and Investment Agreements With Medtronic, a Global Leader in Spine Technologies and Solutions
BusinessWire - Wed May 18, 3:00AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.
MDT: 85.70 (-0.08), MZOR: 15.78 (-0.18)

Mazor Robotics Reports First Quarter Financial Results
BusinessWire - Tue May 10, 3:30AM CDT
--- Conference Call Today at 8:30 AM ET (3:30PM IST) -
MZOR: 15.78 (-0.18)

Medical Robots Transforming Healthcare 2016: Pricing & Cost-Benefit Assessment Featuring Elekta, Hocoma, Intuitive Surgicals, Mazor Robotics, Rewalk & Varian Medical Systems
GlobeNewswire - Wed May 04, 4:10AM CDT
Research and Markets has announced the addition of the "Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment, by Product, by Application, by Geography, Reimbursement, Selection Criteria and Buying Cycle" report to their offering.
VAR: 85.30 (-0.27), MZOR: 15.78 (-0.18)

Miami HCA Affiliate, Mercy Hospital, Installs a Mazor Robotics Renaissance(R) Guidance System for Spine Surgery
BusinessWire - Wed May 04, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of innovative guidance systems and complementary products, recently installed a Renaissance Guidance System at Mercy Hospital in Miami. Mercy Hospital is the sixth HCA-affiliated facility to purchase a Renaissance system and the second hospital in Miami-Dade County to receive a system in the last six months.
MZOR: 15.78 (-0.18)

Mazor Robotics Reports First Quarter Financial Results on May 10, 2016
BusinessWire - Fri Apr 29, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, today announced that it will report financial results for the first quarter ended March 31, 2016, before the U.S. markets open on Tuesday, May 10, 2016.
MZOR: 15.78 (-0.18)

Mazor Robotics Congratulates Baptist Medical Center Jacksonville on Surpassing 700 Procedures with Renaissance(R) Guidance System
GlobeNewswire - Thu Apr 28, 7:05AM CDT
Last week, Neurosurgeon Andrew Cannestra, MD, PhD, performed Baptist Medical Center's 700 case with the Mazor Robotics Renaissance Guidance System. The team at Baptist Medical Center Jacksonville has two Renaissance systems and uses the technology to assist in both spine and brain procedures.
MZOR: 15.78 (-0.18)

Tri-City Medical Center Performs 700 Spine Surgery Cases with Mazor Robotics Renaissance(R) Guidance System
GlobeNewswire - Wed Apr 20, 7:04AM CDT
On April 4, Dr. Payam Moazzaz performed the 700 Mazor Robotics Renaissance Spine Surgery case at Tri-City Medical Center. The Renaissancesystem uses mechanical guidance to help surgeons place pedicle screws and implants with unparalleled accuracy to correct conditions such as scoliosis and degenerative disc disease.
MZOR: 15.78 (-0.18)

Mazor Robotics: Strong Sell as Orders Register a Decline
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 12:00PM CDT
On Apr 14, Zacks Investment Research downgraded Mazor Robotics Ltd (MZOR) to a Zacks Rank #5 (Strong Sell).
VAR: 85.30 (-0.27), GMED: 24.63 (-0.54), INGN: 49.46 (-0.77), MZOR: 15.78 (-0.18)

Mazor Robotics to Present at 15th Annual Needham Healthcare Conference
BusinessWire - Tue Apr 12, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of innovative guidance systems and complementary products, today announced that Sharon Levita, Chief Financial Officer, is scheduled to present at the 15th Annual Needham Healthcare Conference on Wednesday, April 13, 2016 at 10:00am ET at the Westin Grand Central Hotel in New York City.
MZOR: 15.78 (-0.18)

Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 24.63 (-0.54), MZOR: 15.78 (-0.18), ARAY: 5.30 (-0.30), ANGO: 13.50 (-0.01)

Mazor Robotics Receives Five Renaissance System Purchase Orders During First Quarter of 2016
BusinessWire - Tue Apr 05, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of innovative guidance systems and complementary products, announced today that it received orders for five Renaissance systems in the first quarter ended March 31, 2016. The Company installed four systems in the U.S., including one with the brain module, and internationally it received one purchase order from its Australian distribution partner.
MZOR: 15.78 (-0.18)

Mazor Robotics Renaissance System Ordered in New Jersey
Zacks Equity Research - Zacks Investment Research - Fri Mar 18, 11:50AM CDT
Mazor Robotics Ltd. (MZOR) recently announced that NJ-based Robert Wood Johnson (RWJ) University Hospital has ordered for its first Renaissance system.
ABMD: 102.53 (-1.78), MZOR: 15.78 (-0.18), LMNX: 20.38 (-0.42), CRY: 11.88 (-0.10)

100th Robot-Guided Spinal Fusion Surgery Is Performed by Dr. Christopher R. Good of the Virginia Spine Institute
Marketwired - Thu Mar 17, 5:00AM CDT
Dr. Christopher R. Good, Spinal Surgeon at the Virginia Spine Institute, performed his 100th robot-guided spinal fusion surgery at Reston Hospital Center. Dr. Good utilizes the Renaissance Robotic Guidance System(TM), manufactured by Mazor Robotics Ltd., to create blueprints for surgery. The robotic system compliments surgical skills, enabling surgeons to perform procedures with increased precision. Through his leadership and vast experience, Dr. Good is reshaping the future of spine surgery by improving patient safety and reducing recovery time.
MZOR: 15.78 (-0.18)

Mazor Robotics Receives Purchase Order for the Renaissance System from Robert Wood Johnson University Hospital
BusinessWire - Wed Mar 16, 3:30AM CDT
--Represents Third Purchase Order for Renaissance to Date in the 2016 First Quarter
MZOR: 15.78 (-0.18)

Mazor Robotics Q4 Loss Narrows, Revenues Improve Y/Y
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 10:30AM CST
Mazor Robotics (MZOR) reported adjusted loss of 5 cents in the fourth quarter of 2015, which was narrower than the year-ago loss of 7 cents owing to higher revenues.
ABMD: 102.53 (-1.78), MZOR: 15.78 (-0.18), LMNX: 20.38 (-0.42), CRY: 11.88 (-0.10)

Mazor Robotics to Report Fourth Quarter and Full Year Financial Results on February 18, 2016
BusinessWire - Tue Feb 09, 3:30AM CST
Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2015, before the U.S. markets open on Thursday, February 18, 2016.
MZOR: 15.78 (-0.18)

Intuitive Surgical: Integrated Table Motion FDA-Approved
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 10:40AM CST
Intuitive Surgical (ISRG) and Hill-Rom Holdings (HRC) recently announced FDA clearance for the Integrated Table Motion for the da Vinci Xi Surgical System.
ISRG: 641.59 (-6.61), MZOR: 15.78 (-0.18), ARAY: 5.30 (-0.30), HRC: 50.10 (-1.12)

Mazor Robotics to Present at 18th Annual Needham Growth Conference
BusinessWire - Tue Jan 12, 3:05PM CST
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, today announced that Sharon Levita, Chief Financial Officer is scheduled to present at the 18th Annual Needham Growth Conference on Thursday, January 14, 2016 at 8:40am ET at the New York Palace Hotel in New York City.
MZOR: 15.78 (-0.18)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 307

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 107

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 311

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 179

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 0

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 471

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Midi Health and Mount Sinai Team Up for Menopause Care Access

Updated Category News Views 111

Midi Health and Mount Sinai Health System Join Forces Midi Health is excited to announce a new collaboration with Mount Sinai Health System, aimed at improving access to specialized menopause care for women in the New York City area. This partnership represents a crucial step in addressing the unmet needs of women experiencing perimenopausal and menopausal challenges. Why...

Continue Reading
Surety One, Inc.'s Charitable Matching Program Empowers Employees

Updated Category News Views 191

Surety One, Inc. Launches Charitable Matching Initiative Surety One, Inc. recently announced a noteworthy initiative: a corporate charitable matching program aimed at amplifying employee generosity. Through this program, the company will match employee donations to approved nonprofit organizations, offering a dollar-for-dollar match up to $2,500 per employee annually....

Continue Reading
Exploring Microsoft Stock's Seasonal Performance Before Earnings

Updated Category News Views 307

Could Now Be the Right Time to Invest in Microsoft? As Microsoft Corp. (NASDAQ: MSFT) prepares to unveil its fiscal first-quarter earnings soon, the question on the minds of many investors is whether now is an opportune moment to dive into this tech giant's stock. Data suggests a compelling case for this. Microsoft's Persuasive Seasonal Patterns Historically, the period...

Continue Reading
Foresight Technology VCT Reinforces Market Presence Through Buyback

Updated Category News Views 118

Strategic Share Buyback by Foresight Technology VCT PLC FORESIGHT TECHNOLOGY VCT PLC LEI: 21380013CXOR8N6OD977 The Board of Foresight Technology VCT plc has embarked on a strategic move to enhance its market dynamics. Recently, the Company executed a buyback, acquiring 35,274 of its FWT shares at a gross price of 87.88p each. This transaction occurred on the 24th of...

Continue Reading
Quarterhill's Virtual Annual Meeting Highlights Upcoming Changes

Updated Category News Views 157

Quarterhill's Virtual Annual Meeting Details Quarterhill Inc. is gearing up for its Annual and Special Meeting of shareholders, which will take place virtually. This exciting opportunity allows registered shareholders and proxyholders to participate actively by asking questions and voting in real time. They must follow the instructions mentioned in Quarterhill's...

Continue Reading